Engineering spatial control of multiple differentiation fates within a stem cell population

Biomaterials

Volumn 32, Issue 13, 2011, Pages 3413-3422

  Ker, Elmer D F ^a   Chu, Bur ^a,b   Phillippi, Julie A ^d   Gharaibeh, Burhan ^e   Huard, Johnny ^e   Weiss, Lee E ^a,c   Campbell, Phil G ^a,b  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

BMP (bone morphogenetic protein); Bone; ECM (extracellular matrix); Fibroblast growth factor; Muscle; Tendon

Indexed keywords

BMP (BONE MORPHOGENETIC PROTEIN); BONE MORPHOGENETIC PROTEIN-2; C2C12 MYOBLASTS; CELL POPULATIONS; ECM (EXTRACELLULAR MATRIX); EXTRACELLULAR MATRICES; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR-2; IMMUNOFLUORESCENCE STAINING; MUSCLE-DERIVED STEM CELLS; MYOCYTES; MYOFIBROBLASTS; MYOTUBES; OSTEOBLAST MARKERS; QUANTITATIVE PCR; SMOOTH MUSCLE ACTINS; SOLID-PHASE; SPATIAL CONTROL; TENDON MARKERS; TENOCYTE; TISSUE UNITS;

BONE; CELL CULTURE; CELL PROLIFERATION; FIBROBLASTS; MUSCLE; PEPTIDES; POLYMERASE CHAIN REACTION; REPAIR; STEM CELLS; TENDONS; TRANSCRIPTION FACTORS;

OSTEOBLASTS;

ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN 2; CELL MARKER; FIBRIN; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SCLERAXIS; TRANSCRIPTION FACTOR ERM; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR PEA3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL POPULATION; CELL REGENERATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; IMMOBILIZED CELL; IMMUNOFLUORESCENCE; INKJET BASED BIOPRINTER; MATERIAL COATING; MESENCHYME CELL; MOUSE; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; OSTEOBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; PRINTING; PRIORITY JOURNAL; TENDON; TENOCYTE; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; MICE; MYOBLASTS; OSTEOBLASTS; POLYMERASE CHAIN REACTION; STEM CELLS; TENDONS;

EID: 79952006667     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.01.036     Document Type: Article

References (54)

1. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441(7097):1075-1079.
2. Nelson C.M., Bissell M.J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2006, 22:287-309.
3. Taipale J., Keski-Oja J. Growth factors in the extracellular matrix. Faseb J 1997, 11(1):51-59.
4. Canalis E. Growth factor control of bone mass. J Cell Biochem 2009, 108(4):769-777.
5. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factor 2004, 22(4):233-241.
6. Choi Y.J., Lee J.Y., Park J.H., Park J.B., Suh J.S., Choi Y.S., et al. The identification of a heparin binding domain peptide from bone morphogenetic protein-4 and its role on osteogenesis. Biomaterials 2010, 31(28):7226-7238.
7. Unsicker K., Krieglstein K. Cell signaling and growth factors in development 2006, WILEY-VCH, Germany.
8. Campbell P.G., Miller E.D., Fisher G.W., Walker L.M., Weiss L.E. Engineered spatial patterns of FGF-2 immobilized on fibrin direct cell organization. Biomaterials 2005, 26(33):6762-6770.
9. Carinci P., Becchetti E., Baroni T., Carinci F., Pezzetti F., Stabellini G., et al. Extracellular matrix and growth factors in the pathogenesis of some craniofacial malformations. Eur J Histochem 2007, 51(Suppl. 1):105-115.
10. Cooper G.M., Miller E.D., Decesare G.E., Usas A., Lensie E.L., Bykowski M.R., et al. Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation. Tissue Eng Part A 2010, 16(5):1749-1759.
11. Datta N., Holtorf H.L., Sikavitsas V.I., Jansen J.A., Mikos A.G. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 2005, 26(9):971-977.
12. DeCarlo A.A., Whitelock J.M. The role of heparan sulfate and perlecan in bone-regenerative procedures. J Dent Res 2006, 85(2):122-132.
13. Miller E.D., Fisher G.W., Weiss L.E., Walker L.M., Campbell P.G. Dose-dependent cell growth in response to concentration modulated patterns of FGF-2 printed on fibrin. Biomaterials 2006, 27(10):2213-2221.
14. Miller E.D., Phillippi J.A., Fisher G.W., Campbell P.G., Walker L.M., Weiss L.E. Inkjet printing of growth factor concentration gradients and combinatorial arrays immobilized on biologically-relevant substrates. Comb Chem High Throughput Screen 2009, 12(6):604-618.
15. Nelson C.M., Tien J. Microstructured extracellular matrices in tissue engineering and development. Curr Opin Biotechnol 2006, 17(5):518-523.
16. Phillippi J.A., Miller E., Weiss L., Huard J., Waggoner A., Campbell P. Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and bone-like subpopulations. Stem Cells 2008, 26(1):127-134.
17. Ruhrberg C., Gerhardt H., Golding M., Watson R., Ioannidou S., Fujisawa H., et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002, 16(20):2684-2698.
18. Schultz G.S., Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009, 17(2):153-162.
19. Wiradjaja F., DiTommaso T., Smyth I. Basement membranes in development and disease. Birth Defects Res C Embryo Today 2010, 90(1):8-31.
20. de Juan-Pardo E.M., Hoang M.B., Conboy I.M. Geometric control of myogenic cell fate. Int J Nanomedicine 2006, 1(2):203-212.
21. Flaim C.J., Teng D., Chien S., Bhatia S.N. Combinatorial signaling microenvironments for studying stem cell fate. Stem Cells Dev 2008, 17(1):29-39.
22. Ilkhanizadeh S., Teixeira A.I., Hermanson O. Inkjet printing of macromolecules on hydrogels to steer neural stem cell differentiation. Biomaterials 2007, 28(27):3936-3943.
23. Lee Y.B., Polio S., Lee W., Dai G., Menon L., Carroll R.S., et al. Bio-printing of collagen and VEGF-releasing fibrin gel scaffolds for neural stem cell culture. Exp Neurol 2010, 223(2):645-652.
24. Cserjesi P., Brown D., Ligon K.L., Lyons G.E., Copeland N.G., Gilbert D.J., et al. Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 1995, 121(4):1099-1110.
25. Scott A., Sampaio A., Abraham T., Duronio C., Underhill T.M. Scleraxis expression is coordinately regulated in a murine model of patellar tendon injury. J Orthop Res 2011, 29(2):289-296.
26. Gharaibeh B., Lu A., Tebbets J., Zheng B., Feduska J., Crisan M., et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc 2008, 3(9):1501-1509.
27. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002, 157(5):851-864.
28. Miller E. Inkjet printing of solid-phase growth factor patterns to direct cell fate [Doctor of Philosophy] 2007, Carnegie Mellon University, Pittsburgh.
29. Jadlowiec J., Dongell D., Smith J., Conover C., Campbell P. Pregnancy-associated plasma protein-a is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick chorioallontoic membrane. Endocrinology 2005, 146(9):3765-3772.
30. Jadlowiec J., Koch H., Zhang X., Campbell P.G., Seyedain M., Sfeir C. Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway. J Biol Chem 2004, 279(51):53323-53330.
31. Brent A.E., Tabin C.J. FGF acts directly on the somitic tendon progenitors through the Ets transcription factors Pea3 and Erm to regulate scleraxis expression. Development 2004, 131(16):3885-3896.
32. Springer M.L., Ozawa C.R., Blau H.M. Transient production of alpha-smooth muscle actin by skeletal myoblasts during differentiation in culture and following intramuscular implantation. Cell Motil Cytoskeleton 2002, 51(4):177-186.
33. Clayton R.A., Court-Brown C.M. The epidemiology of musculoskeletal tendinous and ligamentous injuries. Injury 2008, 39(12):1338-1344.
34. Yang P.J., Temenoff J.S. Engineering orthopedic tissue interfaces. Tissue Eng Part B Rev 2009, 15(2):127-141.
35. Chan J., O'Donoghue K., Gavina M., Torrente Y., Kennea N., Mehmet H., et al. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 2006, 24(8):1879-1891.
36. Elia D., Madhala D., Ardon E., Reshef R., Halevy O. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 2007, 1773(9):1438-1446.
37. Filigheddu N., Gnocchi V.F., Coscia M., Cappelli M., Porporato P.E., Taulli R., et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell 2007, 18(3):986-994.
38. Georgiadis V., Stewart H.J., Pollard H.J., Tavsanoglu Y., Prasad R., Horwood J., et al. Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration. Dev Dyn 2007, 236(4):1014-1024.
39. Gros J., Serralbo O., Marcelle C. WNT11 acts as a directional cue to organize the elongation of early muscle fibres. Nature 2009, 457(7229):589-593.
40. Horsley V., Jansen K.M., Mills S.T., Pavlath G.K. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 2003, 113(4):483-494.
41. Kim D., Chi S., Lee K.H., Rhee S., Kwon Y.K., Chung C.H., et al. Neuregulin stimulates myogenic differentiation in an autocrine manner. J Biol Chem 1999, 274(22):15395-15400.
42. Kishioka Y., Thomas M., Wakamatsu J., Hattori A., Sharma M., Kambadur R., et al. Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity. J Cell Physiol 2008, 215(3):856-867.
43. Kocamis H., Gulmez N., Aslan S., Nazli M. Follistatin alters myostatin gene expression in C2C12 muscle cells. Acta Vet Hung 2004, 52(2):135-141.
44. Sorci G., Riuzzi F., Arcuri C., Giambanco I., Donato R. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol Cell Biol 2004, 24(11):4880-4894.
45. Straface G., Aprahamian T., Flex A., Gaetani E., Biscetti F., Smith R.C., et al. Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration. J Cell Mol Med 2009, 13(8B):2424-2435.
46. Blau H.M., Pavlath G.K., Hardeman E.C., Chiu C.P., Silberstein L., Webster S.G., et al. Plasticity of the differentiated state. Science 1985, 230(4727):758-766.
47. Goichberg P., Geiger B. Direct involvement of N-cadherin-mediated signaling in muscle differentiation. Mol Biol Cell 1998, 9(11):3119-3131.
48. Edom-Vovard F., Schuler B., Bonnin M.A., Teillet M.A., Duprez D. Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons. Dev Biol 2002, 247(2):351-366.
49. Hoffmann A., Pelled G., Turgeman G., Eberle P., Zilberman Y., Shinar H., et al. Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest 2006, 116(4):940-952.
50. Wolfman N.M., Hattersley G., Cox K., Celeste A.J., Nelson R., Yamaji N., et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest 1997, 100(2):321-330.
51. Morin R., Kaplan D., Perez-Ramirez B. Bone morphogenetic protein-2 binds as multilayers to a collagen delivery matrix: an equilibrium thermodynamic analysis. Biomacromolecules 2006, 7(1):131-138.
52. Sahni A., Odrljin T., Francis C.W. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998, 273(13):7554-7559.
53. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005, 122(2):289-301.
54. Quarto N., Wan D.C., Longaker M.T. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone 2008, 42(6):1040-1052.